ELECTROMED INC
ELMDNYSE AMERICANTrading Snapshot
- Day Range
- β
- 52-Week Range
- $23.01 β $47.40
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 8.3M
- Next Earnings
- 2026-11-10
Fundamentals Snapshot
- Annual Revenue
- $74M
- Last Q Revenue
- $19M
- P/E Ratio
- 20.0
- P/S Ratio
- 3.1x
- EPS (TTM)
- $1.30
- Dividend Yield
- β
- Dilution (1yr)
- +0.0%
ELECTROMED INC
ELMDAbout ELECTROMED INC
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
βLatest News & Updates
News unavailable.